SEC Form 5 · accession 0001209191-15-007603
IMMUNIC, INC. · IMUX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Terence E. Winters
Officer — Co-Chairman and CEO · Director
Period of report
Dec 31, 2014
Accepted (ET)
Jan 29, 2015 · 7:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001280776
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 29, 2014 | G | 3,240 | $0.00 | D | 182,136 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported dispositions represent gifts of shares to family members. The gifted shares remain subject to lock-up agreements with the issuer pursuant to which the transferees agreed, subject to certain exceptions, not to dispose of or hedge any of these shares through the second full trading day following the date of issuance of a press release that includes topline data from Vital Therapies' VTI-208 Phase 3 clinical trial, except with the prior written consent of the issuer's board of directors. The reporting person disclaims any direct or indirect beneficial ownership in the gifted shares.